
Human Histone H4.1 90-103, ALKRQGRTLYGFGG
Description
About Human Histone H4.1 90-103, ALKRQGRTLYGFGG
The Human Histones H4.1 Peptide (IEDB: 419495) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Histones Peptide, H-ALKRQGRTLYGFGG-OH (Uniprot: P62805 aa: 90-103) from JPT is produced under strict quality control and quality management.
Human Histone H4.1 90-103, ALKRQGRTLYGFGG - Specifications
- Peptide sequence: H-ALKRQGRTLYGFGG-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Breast cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Histone H4.1 90-103, ALKRQGRTLYGFGG
References:
Read References with JPT’s Antigen Peptides
Human Histone H4.1 90-103, ALKRQGRTLYGFGG has been described in:
Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells., J Virol, 2015 (PMID: 25810538)
Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires., Immunogenetics, 2015 (PMID: 25502872)
Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients., Prostate, 2005 (PMID: 15378520)
Documentation
Documentation for Human Histone H4.1 90-103, ALKRQGRTLYGFGG
Properties
Properties of Human Histone H4.1 90-103, ALKRQGRTLYGFGG
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Breast cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Histones |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Histone H4.1 90-103, ALKRQGRTLYGFGG
Information | Values |
---|---|
Sequence: | H-ALKRQGRTLYGFGG-OH |
Specifications: | 14mer peptide as TFA salt |